Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases

Idiopathic Pulmonary Fibrosis Clinical Trials

A listing of Idiopathic Pulmonary Fibrosis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 Last 

Alabama

University of Alabama - Birmingham
Birmingham Alabama 35294
Updated

A clinical research study for the treatment of Idiopathic Pulmonary Fibrosis

University of Alabama at Birmingham - Division of Pulmonary, Allergy & Criticial Care
Birmingham Alabama 35294-0006
Updated

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

University of Alabama at Birmingham
Birmingham Alabama 35294

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Research Site
Birmingham Alabama

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

The Kirklin Clinic
Birmingham Alabama 35294

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Arizona

Arizona Pulmonary Specialists
Phoenix Arizona 85012

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

St. Joseph's Hospital and Medical Center - Heart Lung Institute/ Clinical Research
Phoenix Arizona 85013
Updated

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Arizona Pulmonary Specialists, Ltd.
Phoenix Arizona 85012

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Saint Joseph's Hospital and Medical Center
Phoenix Arizona 85103

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Research Site
Phoenix Arizona

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

View More »

Scottsdale Arizona 85259

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Arizona Pulmonary Specialists, Ltd.
Scottsdale Arizona 85258

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Mayo Clinic Arizona
Scottsdale Arizona 85259

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Research Site
Scottsdale Arizona

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

Arizona Pulmonary Specialists, LTD
Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

University of Arizona
Tucson Arizona 85704

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Tucson Arizona 85723

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

The University of Arizona
Tucson Arizona 85724

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

California

University California-San Francisco
San Francisco California 94143
Updated

STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

View More »

La Jolla California 92093

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

University of California San Diego
La Jolla California 92093

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Research Site
La Jolla California

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

VA Greater LA Health Care System-UCLA
Los Angeles California 90073

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

Cedars-Sinai Medical Center
Los Angeles California 90048
Updated

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

David Geffen School of Medicine at UCLA
Los Angeles California 90095
Updated

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

David Geffen School of Medicine at University of California, Los Angeles
Los Angeles California 90024

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

David Geffen School of Medicine UCLA
Los Angeles California 90095-1690

A clinical trial seeking patients for a research study for the treatment of Pulmonary Arterial Hypertension, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease or Pulmonary Hypertension

David Geffen School of Medicine, UCLA
Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating treprostinil for the treatment of Pulmonary Arterial Hypertension, Interstitial Lung Disease or Idiopathic Pulmonary Fibrosis

Departments of Pulmonary and Critical Care, Cardiothoracic Surgery and Infectious Diseases at David Geffen School of Medicine at UCLA
Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

David Geffen School of Medicine UCLA
Los Angeles California 90095-1690

Patients are needed to participate in a clinical research study of bosentan and No specific intervention to evaluate Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

David Geffen School of Medicine at UCLA
Los Angeles California 90024

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

University of California- Davis Medical Center
Sacramento California 95817

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

University of California Davis Medical Center
Sacramento California 95817

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Research Site
Sacramento California

A clinical trial to evaluate treatments using Tralokinumab and Placebo for patients with Idiopathic Pulmonary Fibrosis

UC Davis Medical Center
Sacramento California 95817

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

University of California at San Francisco
San Francisco California 94143
Updated

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

University of California San Francisco
San Francisco California 94143

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Sansum Clinic
Santa Barbara California 93105

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Stanford University Medical Center
Stanford California 94305-5236
Updated

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

Stanford University Medical Center
Stanford California 94305

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Colorado

National Jewish Health
Denver Colorado 80206

A clinical research study for the treatment of Pulmonary Arterial Hypertension or Idiopathic Pulmonary Fibrosis

National Jewish Health
Denver Colorado 80206
Updated

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

National Jewish Health
Denver Colorado 80206

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Wheat Ridge Colorado 80033

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Connecticut

1199.187.01007 Boehringer Ingelheim Investigational Site
Danbury Connecticut

A Phase 3 clinical study for patients with Idiopathic Pulmonary Fibrosis

Yale University School of Medicine, Section of Pulmonary & Critical Care
New Haven Connecticut 06511
Updated

A clinical research study of BMS-986020 and Placebo matching with BMS-986020 for the treatment of Idiopathic Pulmonary Fibrosis

New Haven Connecticut 06520

A clinical research study of lebrikizumab and placebo for the treatment of Idiopathic Pulmonary Fibrosis

Yale University School of Medicine
New Haven Connecticut 06150

A clinical research study of Simtuzumab (GS-6624) and Placebo for the treatment of Idiopathic Pulmonary Fibrosis

Yale University
New Haven Connecticut 06520

Patients are needed to participate in a clinical research study of FG-3019 and Placebo to evaluate Idiopathic Pulmonary Fibrosis

Florida

First 1 2 3 4 5 6 7 8 9 Last